Novo Nordisk A/S ADR (NY: NVO )

Pfizer's Aggressive Stance In Obesity Drugs: CEO Albert Bourla Confirms Bold Bet Despite Prior Drug Hurdles

January 09, 2024

Monday, at the JP Morgan Healthcare Conference, Pfizer Inc (NYSE: PFE) CEO Albert Bourla expressed that the company is determined to move forward in the burgeoning

Via Benzinga

Can Simply Good Foods ride the GLP-1 weight loss trend in 2024?

January 09, 2024

Simply Good Foods may be ready to breakout as the GLP-1 medication weight-loss trend is driving up sales for its Atkins and Quest Nutrition branded products

Novo Nordisk's Wegovy has been linked to greater weight loss with prolonged use, with 40% of patients still using the drug a year later. This adherence rate is three times higher than other...

Ozempic Users Might Experience Caloric Intake Rise Post-Discontinuation: Survey

January 08, 2024

Via Benzinga

Dexcom's Recent 66% Run Continues With A Breakout On Bullish Fourth-Quarter Sales

January 08, 2024

Dexcom beat fourth-quarter sales expectations and issued stronger-than-usual annual guidance.

This company is steadily gaining in value, and its growth runway is quite long, too.

Could Novo Nordisk Stock Help You Retire a Millionaire?

January 08, 2024

Wegovy and Ozempic Maker Novo Nordisk Shares Data From Phase 3 Diabetes Study Of Semaglutide/Insulin Containing Candidate

Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity

January 05, 2024

Via Benzinga

January 08, 2024

Novo Nordisk A/S (NYSE: NVO) announced topli

Via Benzinga

Voyager Therapeutics stock pops 30% on deal with Novartis

January 08, 2024

Voyager Therapeutics Inc. (NASDAQ: VYGR) is a biotech in the medical sector that specializes in gene therapy for neurological diseases. Its shares took

EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:PFE),(NYSE:MRK),(NASDAQ:AZN),(NYSE:NVO) EQNX::TICKER_END

Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs

January 08, 2024

Via Investor Brand Network

Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs

January 08, 2024

Via FinancialNewsMedia

2 low-priced gene therapy stocks to speculate on

January 08, 2024

Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic diffe

HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.

Exposures Product Safety

HCA Healthcare Rallies: Weight-loss drugs really a big threat?

January 08, 2024

Nvidia could make some noise with its CES presentation Monday.

Topics ETFs

Nvidia, Spotify Lead Five Stocks Near Buy Points

January 06, 2024

Investors in Weight Watchers and WW stock are seeing more declines today, as investors price in the impact of a rival's new site.

Why Is WeightWatchers (WW) Stock Down 5% Today?

January 05, 2024

Tesla, Apple and Mobileye were key losers.

Stock Market Skids To Start 2024 As Tesla, Apple Stumble, Mobileye Crashes: Weekly Review

January 05, 2024

Novo Nordisk's Ozempic And Wegovy Helps Lose Weight, Not One's Mind: US Study Find No Increased Suicidal Thoughts Risk

January 05, 2024

On Friday, a comprehensive U.S.

Via Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

January 05, 2024

Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.

Via Benzinga

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024

January 05, 2024

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.

Participate in the growth of the global economy and consumption through these leading global stocks for 2024.

Global Giants: 3 Multinational Corporations to Outperform in 2024

January 04, 2024

The company just boosted its research and development efforts.

Topics Economy

Exposures Economy

Why Novo Nordisk Stock Crushed the Market Today

January 04, 2024

Eli Lilly Launches Website To Help Patients With Home Delivery Options For Weight Loss Medicines

10 Health Care Stocks Whale Activity In Today's Session

January 04, 2024

Via Benzinga

January 04, 2024

Eli Lilly announced a new website allowing patients to get a weight loss drug prescription through a telehealth provider, with disease management resources, home delivery of medicines.

Via Benzinga

Eli Lilly Beefs Up Its Weight-Loss Marketing Efforts With New Direct-To-Consumer Site

January 04, 2024

Eli Lilly will connect patients with doctors, support and direct-to-home delivery of specific medicines.

Novo Nordisk A/S (NYSE: NVO), Omega Therapeutics Inc (NASDAQ: OMGA), and Cellarity Inc.

Famed Obesity Drug Maker Novo Nordisk Inks Collaborations For Cardiometabolic Diseases

January 04, 2024

Via Benzinga

Is the January Effect reliable indicator for yearly performance?

January 04, 2024

The January Effect refers to January’s market return as predictive of the full year. But is January's performance truly an indicator of how the year may go?

Shares of one new partner nearly doubled after Novo Nordisk pledged to pay up to $532 million.

Topics ETFs

Novo Nordisk, The Weight-Loss Kingpin, Inks Two New Obesity Deals

January 04, 2024

It's not too late to get in on these market beaters.

The Best Stocks to Invest $1,000 in Right Now

January 04, 2024

Omega Therapeutics stock is rising higher on Thursday as investors in OMGA react to a search collaboration agreement with Novo Nordisk.

Why Is Omega Therapeutics (OMGA) Stock Up 111% Today?

January 04, 2024

Pre-market stock movers are a hot topic this morning as we cover all of the biggest market news traders need to know about on Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

January 04, 2024